共 50 条
- [44] Endoscopic Response to Risankizumab in Patients With Refractory Crohn's Disease Who Failed Ustekinumab - Real-World Experience AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S851 - S851
- [45] Real-World Experience and Perspectives on the Treatment of Crohn's Disease: Results From a Health Care Provider Survey AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S19 - S20
- [46] Adalimumab in pediatric Crohn's disease: A long-term multi-centre real-world experience JOURNAL OF CROHNS & COLITIS, 2020, 14 : S491 - S492
- [47] Early infliximab use is associated with less disease progression in luminal Crohn's disease: a real-world tertiary centre experience JOURNAL OF CROHNS & COLITIS, 2025, 19
- [49] Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S834 - S834
- [50] Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):